Shingles Treatment
For treatment of shingles (herpes zoster), oral antiviral therapy with acyclovir 800 mg 5 times daily for 7-10 days is the standard recommended treatment, which should be initiated at the earliest sign or symptom of herpes zoster. 1
First-Line Antiviral Options
Acyclovir
- Dosage: 800 mg 5 times daily for 7-10 days 1
- Continue until all lesions have scabbed (typically 7-10 days)
- Most effective when started within 72 hours of rash onset
- Common side effect: malaise (11.5%, comparable to placebo at 11.1%) 1
Alternative Antivirals
Valacyclovir
Famciclovir
- Comparable efficacy to acyclovir 3
- More convenient dosing schedule than acyclovir
Dosage Adjustments for Renal Impairment
Acyclovir Adjustment
| Creatinine Clearance (mL/min) | Dose Adjustment for 800 mg |
|---|---|
| >25 | 800 mg every 4 hours, 5 times a day |
| 10-25 | 800 mg every 8 hours |
| 0-10 | 800 mg every 12 hours |
| [1] |
Special Populations
Immunocompromised Patients
- May require longer treatment duration and closer monitoring 1
- Consider consultation with infectious disease specialist
Pregnant Patients
- Acyclovir can be safely used due to established safety profile 1
Herpes Zoster Ophthalmicus
- Requires prompt treatment
- Ophthalmology consultation recommended 1
- Same antiviral medications but with closer monitoring
Pain Management
Acute Pain
- Mild pain: Acetaminophen or NSAIDs
- Moderate to severe pain: Consider adding:
- Gabapentin (titrate to 2400 mg per day in divided doses)
- Pregabalin
- Tricyclic antidepressants 1
Postherpetic Neuralgia
- First-line options:
- Gabapentin
- Pregabalin
- Tricyclic antidepressants
- Topical options:
Monitoring and Follow-up
- Schedule follow-up within 7 days to assess treatment response 1
- Monitor for:
- Complete resolution of lesions
- Signs of dissemination or complications
- Need for ophthalmology evaluation if ocular involvement suspected
Treatment Failure
- If lesions don't begin to resolve within 7-10 days of starting therapy, suspect treatment failure
- Consider viral culture and susceptibility testing for suspected acyclovir-resistant HSV
- IV foscarnet is the treatment of choice for acyclovir-resistant cases 1
Prevention
- Vaccination with herpes zoster vaccine is recommended for adults 50 years and older 1, 4
- The CDC's Advisory Committee on Immunization Practices specifically recommends this vaccine for adults 60 years and older 4
Common Pitfalls to Avoid
- Delayed treatment - Efficacy decreases when treatment is started >72 hours after rash onset
- Inadequate pain management - Pain control should be addressed concurrently with antiviral therapy
- Missing ocular involvement - Always check for eye involvement, especially with rash on forehead or nose
- Insufficient treatment duration - Continue treatment until all lesions have crusted over
- Overlooking renal function - Dose adjustment is critical in patients with renal impairment